Recruiting Proof-of-Concept Trial to Assess the Efficacy and Safety of Fezolinetant in Improving Vasomotor Symptoms in Men With Prostate Cancer Undergoing Androgen Deprivation Therapy NCT06957691 Conditions Adenocarcinoma, Androgen Ablative Therapy of Advanced Hormone-dependent Prostate Carcinoma, Androgen Deprivation Therapy, +40 more Locations Brigham and Women's Hospital — Boston, Massachusetts, United States View Trial Details
Completed Androgen-Deprivation Therapy and Cardiovascular Risk: A Nationwide Population-based Cohort Study NCT02895230 Conditions Androgen-deprivation Therapy, Brain Diseases, Cardiovascular Diseases, +25 more Locations CHU de Rennes — Rennes, France View Trial Details
